| Bioactivity | LB-102 is an orally active inhibitor of dopamine D2, D3, and 5-HT7 receptors, which can be used in research on schizophrenia and other psychiatric disorders[1]. |
| CAS | 2227154-23-4 |
| Formula | C18H29N3O4S |
| Molar Mass | 383.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wong D F, et al. PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement[J]. Neuropsychopharmacology, 2024: 1-6. |